Mia Kapun

Antibody-drug conjugates (ADCs) are an emerging class of targeted therapeutic, typically for use in the treatment of cancers…

Antibody-drug conjugates (ADCs) are a cutting-edge class of cancer-targeting therapeutic agents that can achieve a wide therapeutic window by combining the selectivity of a monoclonal antibody (mAb) with the antitumor activity of a cytotoxic payload…